30 Day Trial
BARE BONES logo

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

SeaSpine Reports 1Q19 Revenue of $36.2MM, +9% vs. 1Q18 -

By Mike Evers, ORTHOWORLD

SeaSpine reported 1Q19 revenue of USD $36.2MM, +9% vs. 1Q18.

  • Increased 2019 guidance by $2MM (1.5%) on the low end, bringing updated guidance range to $154MM to $156MM (+7.5 to 9% vs. 2018)
  • Spine revenue growth driven by new products, particularly the Shoreline and Mariner systems along with NanoMetalene products
  • Orthobiologics revenue growth driven by new products such as OsteoStrand Plus
  • Ex-U.S. revenue grew 14.5%, primarily on the strength of Europe

 

Segment sales and growth on an as-reported basis:

  1Q19 1Q18 $ Chg % Chg
Spine $17.1 $15.2 $2.0 13.0%
Orthobiologics $19.0 $18.0 $1.0 5.6%
Total $36.2 $33.2 $3.0 9.0%

Revenue by geographic region:

Geographic Region 1Q19 1Q18 $ Chg % Chg
US $32.0 $29.5 $2.4 8.3%
Ex-US $4.2 $3.6 $0.5 14.5%
Total $36.2 $33.2 $3.0 9.0%

Net earnings:

1Q19 Amount ($MM) % of Sales
Sales $36.2  
   Cost of Sales -$13.6 37.6%
   Other -$0.74 2.0%
   R & D -$3.5 9.7%
   Selling and Admin -$27.3 75.5%
Net Earnings -$9.0 -24.9%

 

Sources: SeaSpine

Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.